The straight and narrow: A game theory model of broadand narrow-spectrum empiric antibiotic therapy

被引:1
|
作者
Diamant, Maya [1 ,2 ,3 ]
Obolski, Uri [2 ,3 ]
机构
[1] Tel Aviv Univ, Coller Sch Management, Tel Aviv, Israel
[2] Tel Aviv Univ, Sch Publ Hlth, Tel Aviv, Israel
[3] Tel Aviv Univ, Porter Sch Environm & Earth Sci, IL-6997801 Tel Aviv, Israel
基金
以色列科学基金会;
关键词
Antibiotics; Antibiotic resistance; Game theory; Medical decision making; Social dilemma; INFECTIOUS-DISEASES SOCIETY; CLINICAL-PRACTICE GUIDELINE; RESISTANCE; ASSOCIATION; MANAGEMENT;
D O I
10.1016/j.mbs.2024.109203
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Physicians prescribe empiric antibiotic treatment when definitive knowledge of the pathogen causing an infection is lacking. The options of empiric treatment can be largely divided into broadand narrow-spectrum antibiotics. Prescribing a broad-spectrum antibiotic increases the chances of covering the causative pathogen, and hence benefits the current patient's recovery. However, prescription of broad-spectrum antibiotics also accelerates the expansion of antibiotic resistance, potentially harming future patients. We analyse the social dilemma using game theory. In our game model, physicians choose between prescribing broad and narrow- spectrum antibiotics to their patients. Their decisions rely on the probability of an infection by a resistant pathogen before definitive laboratory results are available. We prove that whenever the equilibrium strategies differ from the socially optimal policy, the deviation is always towards a more excessive use of the broadspectrum antibiotic. We further show that if prescribing broad-spectrum antibiotics only to patients with a high probability of resistant infection is the socially optimal policy, then decentralization of the decision making may make this policy individually irrational, and thus sabotage its implementation. We discuss the importance of improving the probabilistic information available to the physician and promoting centralized decision making.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] NARROW-SPECTRUM EMPIRIC ANTIMICROBIAL THERAPY FOR VAP IN CRITICALLY ILL TRAUMA PATIENTS
    Krohn, Holly
    Roth, Jennifer
    Colley, Peter
    Funk, Geoffrey
    Foreman, Michael
    CRITICAL CARE MEDICINE, 2018, 46 (01) : 328 - 328
  • [2] A Refunding Scheme to Incentivize Narrow-Spectrum Antibiotic Development
    Boettcher, Lucas
    Gersbach, Hans
    BULLETIN OF MATHEMATICAL BIOLOGY, 2022, 84 (06)
  • [3] A Refunding Scheme to Incentivize Narrow-Spectrum Antibiotic Development
    Lucas Böttcher
    Hans Gersbach
    Bulletin of Mathematical Biology, 2022, 84
  • [4] The Narrow-Spectrum Antibiotic Treatment Score: A Novel Quantitative Tool for Assessing Broad- and Narrow-Spectrum Antibiotic Use in Severe Community-Acquired Pneumonia
    Wang, A. A.
    Pickens, C. O.
    He, H.
    Scholtens, D. M.
    Pawlowski, A. E.
    Singer, B. D.
    Kruser, J. M.
    Walter, J. M.
    Donnelly, H.
    Wunderink, R. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [5] Narrow-spectrum antibacterial agents
    Melander, Roberta J.
    Zurawski, Daniel V.
    Melander, Christian
    MEDCHEMCOMM, 2018, 9 (01) : 12 - 21
  • [6] Chronic Psoriasis efficiency of the narrow-spectrum UVB therapy
    不详
    HAUTARZT, 2010, 61 (12): : 1011 - 1011
  • [7] Drug evaluation: OPT-80, a narrow-spectrum macrocyclic antibiotic
    Johnson, Alan P.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2007, 8 (02) : 168 - 173
  • [8] Narrow-spectrum antibiotic exploits metabolic differences to inhibit Pseudomonas aeruginosa
    Chain, Connor
    Gitai, Zemer
    NATURE MICROBIOLOGY, 2024, 9 (05) : 1165 - 1166
  • [9] Theoretical Development of DnaG Primase as a Novel Narrow-Spectrum Antibiotic Target
    Periago, Jessica
    Mason, Clarissa
    Griep, Mark A.
    ACS OMEGA, 2022, 7 (10): : 8420 - 8428
  • [10] Narrow-spectrum histochemical staining of fungi
    Youngberg, GA
    Wallen, EDB
    Giorgadze, TA
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2003, 127 (11) : 1529 - 1530